Gene · 4923
Papers2,119
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,119
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| N-Terminal Stabilization of Radiolabeled Neurotensin Analogues for Improved Tumor Uptake. | J Med Chem | 2025 | 40111113 | PubTator, text mining | PubMed |
| Enhanced Retention of NTSR1-Targeted Radionuclide Therapeutics via Covalent Inhibitors in Pancreatic, Colorectal, and Prostate Cancer Models. | Mol Pharm | 2025 | 40101018 | PubTator, text mining | PubMed |
| Neurons Co-Expressing GLP-1, CCK, and PYY Receptors Particularly in Right Nodose Ganglion and Innervating Entire GI Tract in Mice. | Int J Mol Sci | 2025 | 40076675 | PubTator, text mining | PubMed |
| Strategies for the Viral Exploitation of Nuclear Pore Transport Pathways. | Viruses | 2025 | 40006906 | PubTator, text mining | PubMed |
| Efficacy of the neurotensin receptor 1 analog PD149163 in modulation of the kidney inflammation: Inhibition of the nuclear factor kappa β signaling pathway and oxidative stress in endotoxemic mice. | Eur J Pharmacol | 2025 | 39978709 | PubTator, text mining | PubMed |
| A thalamic hub-and-spoke network enables visual perception during action by coordinating visuomotor dynamics. | Nat Neurosci | 2025 | 39930095 | PubTator, text mining | PubMed |
| Design and Synthesis of 68Ga-Labeled Peptide-Based Heterodimers for Dual Targeting of NTS1 and GRPR. | ChemMedChem | 2025 | 39908060 | PubTator, text mining | PubMed |
| Neurotensin via Type I Receptor Modulates the Endotoxemia Induced Oxido-Inflammatory Stress on the Sympathetic Adrenomedullary System of Mice Regulating NF-κβ/Nor-Epinephrine Pathway. | Cell Biochem Biophys | 2025 | 39881060 | PubTator, text mining | PubMed |
Neurotensin receptor agonist PD149163 modulates LPS-induced enterocyte apoptosis by downregulating TNFR pathway and executioner caspase 3 in endotoxemic mice: insights from in vivo and in silico study. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 39812770 | PubTator, text mining | PubMed |
| Re-evaluation of Cyclic Peptide Binding to Neurotensin Receptor 1 by Shifting the Peptide Register during Synthesis. | ACS Med Chem Lett | 2025 | 39811130 | PubTator, text mining | PubMed |
| The Influence of Phosphoinositide Lipids in the Molecular Biology of Membrane Proteins: Recent Insights from Simulations. | J Mol Biol | 2025 | 39793883 | PubTator, text mining | PubMed |
| Role of the medial septum neurotensin receptor 1 in anxiety-like behaviors evoked by emotional stress. | Psychoneuroendocrinology | 2025 | 39787865 | PubTator, text mining | PubMed |
| Dual-Lock System for High Sensitivity and Selectivity in Redox Enzyme Activation and Imaging. | Anal Chem | 2025 | 39785120 | PubTator, text mining | PubMed |
| Development of a Class A/B Hybrid GPCR System for the Proximity-Assisted Screening of GPCR Ligands. | ACS Chem Biol | 2025 | 39680855 | PubTator, text mining | PubMed |
| Decreased neurotensin induces ovulatory dysfunction via the NTSR1/ERK/EGR1 axis in polycystic ovary syndrome. | Front Med | 2025 | 39648233 | PubTator, text mining | PubMed |
| A novel androgen-independent radiotracer with dual targeting of NTSR1 and PSMA for PET/CT imaging of prostate cancer. | Eur J Med Chem | 2025 | 39577227 | PubTator, text mining | PubMed |
| Probiotics modulation of the endotoxemic effect on the gut and liver of the lipopolysaccharide challenged mice. | Drug Chem Toxicol | 2025 | 39411878 | PubTator, text mining | PubMed |
| Neurotrophins in Peripheral Neuropathy: Exploring Pathophysiological Mechanisms and Emerging Therapeutic Opportunities. | CNS Neurol Disord Drug Targets | 2025 | 39238380 | PubTator, text mining | PubMed |
| A massively parallel reporter assay library to screen short synthetic promoters in mammalian cells. | Nat Commun | 2024 | 39609378 | PubTator, text mining | PubMed |
| Channel width modulates the permeability of DNA origami-based nuclear pore mimics. | Sci Adv | 2024 | 39536094 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4923/papers?page=6